KMC
SYNH

Kirr Marbach & Co’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Kirr Marbach & Co’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-75,455
Closed -$5.41M – 48
2022
Q2 		$5.41M Buy
75,455
+266
+0.4% +$19.4K 1.7% 29
2022
Q1 		$6.09M Buy
75,189
+3,432
+5% +$290K 1.64% 27
2021
Q4 		$7.37M Buy
+71,757
New +$6.89M 1.95% 24

Other funds holding SYNH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Kirr Marbach & Co's SYNH Position: Q3 2022 in Review

Kirr Marbach & Co sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2022, closing a stake of 75,455 shares — an estimated $5.41M sold.

Kirr Marbach & Co first reported a position in SYNH in Q4 2021 and held it in 3 quarters. The position peaked at $7.37M in Q4 2021. 337 funds tracked by Wall St. Rank hold SYNH as of Q3 2022.

  • Kirr Marbach & Co reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
  • Kirr Marbach & Co sold 75,455 Syneos Health, Inc. Class A Common Stock shares in Q3 2022, an estimated $5.41M.
  • Kirr Marbach & Co first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2021 and held it in 3 quarters.
  • Kirr Marbach & Co's Syneos Health, Inc. Class A Common Stock position peaked at $7.37M in Q4 2021.
  • 337 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2022.

Based on Kirr Marbach & Co's 13F filing for Q3 2022, filed 26 Oct 2022.